Dr. Neeti Sinha has an academic background in diverse scientific fields that include computational molecular biophysics, theoretical thermodynamics, leading physics, and for all purposes of beauty in intricacy and complexity, mathematics. She has many years of research, teaching, and outreaching, experience in leading scientific fields. She holds a DPhil degree in biochemistry from Oxford University, UK. She was a postdoctoral scholar at the National Institutes of Health, following which she worked as an assistant research professor at the Johns Hopkins University. Her work at NIH & Johns Hopkins University involved understanding fundamentals of protein structure-function relations & thermodynamic approaches to computational drug design. Neeti frequently speaks at scientific meetings on topics that inspire the elegance in physics and mathematics, and advanced sciences in general. Find out more about her at her blog: Cosmic Landscape in Quantum Décor. She welcomes a LinkedIn connection. Neeti joined the Antibody Society in March of 2021 as Program Manager, Education & Outreach. Her earlier work on the physical principles of antibody-antigen interactions and her current interest of education and outreach in advanced scientific fields came together to motivate her toward joining the mission of The Antibody Society.
Communications & Membership Committee
Dr. Silvia Crescioli is a senior post doc at King’s College London in Prof. Sophia Karagiannis’ Cancer Antibody Discovery & Immunotherapy Group, where she leads and supervises several projects focused on different areas of cancer immunology and immunotherapy, such as the study of B cells in cancer, antigen/antibody discovery, ADC development, and antibody production, engineering and glycoengineering. Dr. Crescioli received her PhD in Biomedical Sciences, Experimental Oncology, from the University of Florence. @ King’s College London;
Dr. Nick Hutchinson is the Business Steering Group Lead for Mammalian Cell Culture processes at FUJIFILM Diosynth Biotechnologies, a contract development and manufacturing service provider for biopharmaceutical clients. He is part of the Enterprise Business Planning team and focuses on long-term projects, including capital investments and innovation. His expertise is in the biomanufacturing of biopharmaceuticals, in particular antibody therapeutics from cell line development activities through to commercial production. Dr. Hutchinson is currently an Assistant Editor for mAbs and received his Doctorate in Biochemical Engineering from University College London.
Recent presentations and publications:
Hutchinson N. 2020. Antibody Manufacturing Strategies to Address a Pandemic. Festival of Biologics. November 02-06, 2020
Reichert JM & Hutchinson N. 2020. Antibodies to Watch in 2021: Anti-SARS-CoV-2 target therapies to the rescue. The Antibody Society Webinar Series “Antibodies to Watch”. December 3, 2020. Watch it online
Hutchinson N. 2020. Tracking Therapeutic Antibody Development in a Pandemic. BioProcess International. October 2020.